Stereotaxis Q1 Earnings Call Highlights
Stereotaxis, Inc. (STXS) Q1 2026 Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q1 Loss, Lags Revenue Estimates
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
Stereotaxis Stock Up on First U.S. MAGiC Procedures Post Approval
Stereotaxis Announces First MAGiC Procedures in the United States
Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026
Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026
STXS to Acquire Robocath to Lead in Endovascular Robotics Market
Stereotaxis, Inc. (STXS) M&A Call Transcript
Stereotaxis Announces Definitive Agreement to Acquire Robocath
STXS Gains on FDA Nod for Synchrony System, Expands Digital Surgery
Stereotaxis Announces FDA Clearance and Launch of Synchrony System
Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks
Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
Stereotaxis Reports 2025 Full Year Financial Results
Stereotaxis Inc. (NYSEAMERICAN:STXS) Short Interest Update
Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026
Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program
Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter
3 Underrated Robotics Stocks Poised for Huge Gains
Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference
STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics
Stereotaxis, Inc. (STXS) Q3 2025 Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q3 Loss, Misses Revenue Estimates
Stereotaxis Reports 2025 Third Quarter Financial Results
GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance
Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025
Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval
Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs
STXS Partners With CardioFocus to Boost Robotic Pulsed Field Ablation
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias
STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System
Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System
STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep
First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter
Stereotaxis to Present at Upcoming Investor Conferences
Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025
Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates
Stereotaxis Reports 2025 Second Quarter Financial Results
Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter
Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025
Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock
Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial
Stereotaxis: Recurring Revenue Inflection
First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology